Jiangsu Vcare Pharmaceutical Technology Co., Ltd

This study tested a new cream called VC005 on 118 adults with mild to moderate atopic dermatitis (eczema). The goal was to see if it safely reduces eczema symptoms like redness and itching. Participants used the cream or a placebo for a period, and doctors measured changes in the…

This early-phase study tested a new medicine called VC005 in 11 teenagers aged 12 to 18 with mild to moderate atopic dermatitis (eczema). The main goals were to check safety and how the drug moves through the body. Researchers measured drug levels in the blood over time. This is …

This study tested a new blood thinner called vicagrel against the standard drug clopidogrel in 18 healthy adults with a specific gene type. The goal was to see how the body processes each drug and how well they work. Participants took both drugs at different times, and researcher…